Ligand binding to telomeric G-quadruplex DNA investigated by funnel-metadynamics simulations

Federica Moraca1, Jussara Amato2, Francesco Ortuso1

  • 1Dipartimento di Scienze della Salute, University of Catanzaro "Magna Græcia," I-88100 Catanzaro, Italy.

Insights

This study reveals how berberine binds to G-quadruplex DNA structures using funnel-metadynamics. This method accurately predicts binding energy, aiding in the design of new cancer drugs targeting G-quadruplexes.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Structural Biology

Background:

  • G-quadruplexes (G4s) are DNA structures found in gene promoter regions and telomeres.
  • G4 formation impacts DNA replication and can lead to apoptosis, making them targets for cancer therapy.
  • Understanding ligand interactions with G4s is crucial for developing targeted cancer treatments.

Purpose of the Study:

  • To elucidate the binding mechanism of the anticancer alkaloid berberine to the human telomeric G-quadruplex (d[AG3(T2AG3)3]).
  • To compute the binding free-energy landscape of berberine to the G4 structure.
  • To validate a novel free-energy method, funnel-metadynamics (FM), for investigating ligand/DNA interactions.

Main Methods:

  • Utilized funnel-metadynamics (FM) simulations with explicit representation of ions and water molecules.
  • Investigated the binding mechanism and free-energy landscape of berberine to the human telomeric G4.
  • Performed steady-state fluorescence binding assays to validate computational results.

Main Results:

  • Identified two lowest-energy ligand binding modes for berberine on the G4 structure.
  • Discovered prebinding sites that facilitate the final binding mode.
  • Calculated an accurate absolute ligand/DNA binding free energy of -10.3 ± 0.5 kcal/mol.
  • Demonstrated good agreement between theoretical FM predictions and experimental binding assays.

Conclusions:

  • Funnel-metadynamics (FM) is a powerful method for accurately investigating ligand/DNA interactions.
  • The study provides a detailed understanding of berberine's binding mechanism to telomeric G-quadruplex DNA.
  • FM can be a valuable tool for the rational design of novel G-quadruplex-targeting ligands for cancer therapy.